Renal transporters in drug disposition, drug-drug interactions, and nephrotoxicity

Current Protocols in Toxicology

Volumn 1, Issue SUPPL.53, 2012, Pages

  Feng, Bo ^a   El Kattan, Ayman F ^a   Radi, Zaher A ^a  

^a PFIZER INC   (United States)

Author keywords

Drug drug interaction; Nephrotoxicity; Renal transporters

Indexed keywords

NEW DRUG; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 2; ORGANIC ANION TRANSPORTER 3; ORGANIC CATION TRANSPORTER 2; CARRIER PROTEIN; DRUG;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; DNA TRANSFECTION; DRUG DISPOSITION; DRUG INTERACTION; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IC 50; IN VITRO STUDY; INHIBITION KINETICS; NEPHROTOXICITY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INHIBITION; PROTEIN INTERACTION; TOXICOKINETICS; XENOBIOTIC METABOLISM; BIOASSAY; DRUG EFFECT; DRUG SCREENING; KIDNEY; METABOLISM; METHODOLOGY; PHYSIOLOGY; TOXICITY TESTING; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL ASSAY; BIOLOGICAL TRANSPORT; CARRIER PROTEINS; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; HUMANS; KIDNEY; PHARMACEUTICAL PREPARATIONS; TOXICITY TESTS;

EID: 84868127483     PISSN: 19349254     EISSN: 19349262     Source Type: Journal    
DOI: 10.1002/0471140856.tx2303s53     Document Type: Article

References (18)

1. Cha, S.H., Sekine, T., Fukushima, J.I., Kanai, Y., Kobayashi, Y., Goya, T., and Endou, H. 2001. Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol. Pharmacol. 59:1277-1286.
2. Feng, B., LaPerle, J.L., Chang, G., and Varma, M.V. 2010a. Renal clearance in drug discovery and development:Molecular descriptors, drug transporters and disease state. Expert Opin. Drug Metab. Toxicol. 6:939-952.
3. Feng, B., LaPerle, J.L., Chang, G., and Varma, M.V. 2010b. Renal clearance in drug discovery and development:Molecular descriptors, drug transporters and disease state. Expert Opin. Drug Metab. Toxicol. 6:939-952.
4. Giacomini, K.M., Huang, S.M., Tweedie, D.J., Benet, L.Z., Brouwer, K.L., Chu, X., Dahlin, A., Evers, R., Fischer, V., Hillgren, K.M., Hoffmaster, K.A., Ishikawa, T., Keppler, D., Kim, R.B., Lee, C.A., Niemi, M., Polli, J.W., Sugiyama, Y., Swaan, P.W., Ware, J.A., Wright, S.H., Yee, S.W., Zamek-Gliszczynski, M.J., and Zhang, L. 2010. Membrane transporters in drug development. Nat. Rev. Drug Discov. 9:215-236.
5. Gorboulev, V., Ulzheimer, J.C., Akhoundova, A., Ulzheimer-Teuber, I., Karbach, U., Quester, S., Baumann, C., Lang, F., Busch, A.E., and Koepsell, H. 1997. Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell. Biol. 16:871-881.
6. Hosoyamada, M., Sekine, T., Kanai, Y., and Endou, H. 1999. Molecular cloning and functional expression of a multispecific organic anion transporter from human kidney. Am. J. Physiol. 276:F122-F128.
7. Khan, N., Hard, G., and Radi, Z. 2012. Renal toxicity. In New Horizons in Toxicity Prediction: A Comprehensive Overview of the Current Status and Application of Predictive Toxicology. (A.G.E. Wilson, ed.) pp. 499-541. Royal Society of Chemistry, Cambridge.
8. Lee, M.S. 2012. LC/MS Applications in Drug Development. JohnWiley&Sons, Inc., NewYork.
9. Lee, W. and Kim, R.B. 2004. Transporters and renal drug elimination. Annu. Rev. Pharmacol. Toxicol. 44:137-166.
10. Masereeuw, R. and Russel, F.G. 2001. Mechanisms and clinical implications of renal drug excretion. Drug Metab. Rev. 33:299-351.
11. Matsuzaki, T., Watanabe, H., Yoshitome, K., Morisaki, T., Hamada, A., Nonoguchi, H., Kohda, Y., Tomita, K., Inui, K., and Saito, H. 2007. Downregulation of organic anion transporters in rat kidney under ischemia/reperfusion-induced acute [corrected] renal failure. Kidney Int. 71:539-547.
12. Matsuzaki, T., Morisaki, T., Sugimoto, W., Yokoo, K., Sato, D., Nonoguchi, H., Tomita, K., Terada, T., Inui, K., Hamada, A., and Saito, H. 2008. Altered pharmacokinetics of cationic drugs caused by down-regulation of renal rat organic cation transporter 2 (Slc22a2) and rat multidrug and toxin extrusion 1 (Slc47a1) in ischemia/reperfusion-induced acute kidney injury. Drug Metab. Dispos. 36:649-654.
13. Miyazaki, H., Sekine, T., and Endou, H. 2004. The multispecific organic anion transporter family: Properties and pharmacological significance. Trends Pharmacol. Sci. 25:654-662.
14. Mulato, A.S., Ho, E.S., and Cihlar, T. 2000. Nonsteroidal anti-inflammatory drugs efficiently reduce the transport and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1. J. Pharmacol. Exp. Ther. 295:10-15.
15. Okuda, M., Saito, H., Urakami, Y., Takano, M., and Inui, K. 1996. cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem. Biophys. Res. Commun. 224:500-507.
16. Pritchard, J.B. and Miller, D.S. 1993. Mechanisms mediating renal secretion of organic anions and cations. Physiol. Rev. 73:765-796.
17. Ullrich, K.J. 1999. Affinity of drugs to the different renal transporters for organic anions and organic cations. Pharm. Biotechnol. 12:159-179.
18. Varma, M.V., Feng, B., Obach, R.S., Troutman, M.D., Chupka, J., Miller, H.R., and El-Kattan, A. 2009. Physicochemical determinants of human renal clearance. J. Med. Chem. 52:4844-4852.